Le Lézard
Classified in: Covid-19 virus
Subjects: CHI, PER

Edward M. Kennedy Institute Strengthens Its Board with Election of Bruce A. Percelay as Incoming Chairman


BOSTON, July 14, 2020 /PRNewswire/ -- The Edward M. Kennedy Institute for the United States Senate today announced the election of Bruce A. Percelay as its incoming Chairman of the Board. As Founder and Chairman of The Mount Vernon Company, a real estate development and investment firm headquartered in Boston, Percelay brings an extraordinary business acumen and passion for helping others to the Institute at a critical juncture for democracy in the United States.

Most recently, Percelay was the driving force behind Nantucket's new whaling museum and raising more than $120 million for the Nantucket Cottage Hospital, the largest fundraiser for a community hospital ever in U.S. history. Previously, Percelay served as the Chairman for both the Massachusetts chapter of the Make-A-Wish Foundation and Habitat for Humanity in Boston. Currently, Percelay sits on the President's Council at Massachusetts General Hospital as well as the Board of The Rappaport Institute at the Kennedy School of Government.

"The entire Board is delighted to have Bruce Percelay at the helm of the Institute that bears my late husband's name. He is well known in the business community for his innovation and is recognized as a transformational leader in service to the non-profit community," said Victoria Reggie Kennedy, Co-founder and President of the Board at the Edward M. Kennedy Institute. "As our nation grapples with the role of government in addressing the challenges facing our nation, the Kennedy Institute is sharpening its focus on the critical importance of having all Americans exercise the right to vote and be involved in the civic life of their communities. Bruce's exceptional leadership and ability to convene have set us on a path to reaffirm the Institute's role in inspiring the next generation of citizens and leaders to engage in our democracy."

Since opening its doors five years ago, the Kennedy Institute has welcomed tens of thousands of school age children and young adults into its full-scale replica of the U.S. Senate Chamber to negotiate, vote on legislation, and experience, for a day, what it means to work as a U.S. senator. Through a blend of award-winning experiential learning and interactive digital experiences, the Kennedy Institute is transforming the paradigm for civic education and participatory democracy. Like many cultural institutions facing the realities of the global COVID-19 pandemic, the Kennedy Institute has increased its focus on delivering quality programming in virtual/digital learning environments, with an upcoming slate of voting-focused offerings anticipated for later this summer.

"I am honored to join the Board as Chairman of this cutting-edge institution," said Percelay. "I share Senator Kennedy's belief that inspired, engaged, and knowledgeable citizens are vital for our democracy to be successful and to flourish. During these unprecedented times of national health crisis and civil unrest, the work of the Edward M. Kennedy Institute has never been more important and needed than it is right now. I look forward to working with my fellow Board members and the dedicated staff of the Institute to make a meaningful difference during this pivotal time."

About the Edward M. Kennedy Institute
The Edward M. Kennedy Institute for the United States Senate is dedicated to educating the public about the important role of the Senate in our government, encouraging participatory democracy, invigorating civil discourse, and inspiring the next generation of citizens and leaders to engage in the civic life of their communities. Learn more via www.emkinstitute.org.  

MEDIA CONTACT
Miles Halpine
[email protected]  
857.271.3372

SOURCE Edward M. Kennedy Institute


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: